SAN DIEGO, April 8 /PRNewswire-FirstCall/ -- Accelrys Inc. today announced
the commercial availability of five additional Accelrys software applications
on IBM eServer* pSeries* systems running AIX*. This is the second group of
product releases resulting from the global strategic alliance between IBM and
Accelrys that was announced in January of this year. The alliance seeks to
enhance drug research and development (R&D) operations by creating a
collaborative information technology environment to help chemists and
biologists develop new drugs faster, more efficiently, and at lower costs.
"This new milestone reflects the commitment and aggressive timetable IBM
and Accelrys have set to deliver innovative information technologies through
our alliance," said Mike Svinte, vice president of Worldwide Business
Development, IBM Life Sciences. "We have now enabled ten of Accelrys' leading
life sciences applications to run optimally on IBM's servers, and more
applications are in the pipeline. This is good news for customers who need
powerful solutions to improve the efficiency of their pharmaceutical R&D
The second set of Accelrys applications optimized to run on IBM eServer
pSeries systems, including the new p690 server code named "Regatta," are RS3,
CNX, and HypoGen, HipHop, and Confirm from the Catalyst(R) suite. These
additional applications broaden Accelrys' suite of IBM ported applications to
a total of ten diversified products with functionalities supporting
bioinformatics, cheminformatics, modeling, and analytics. Over the next three
quarters of 2002, Accelrys will continue to collaborate with IBM to migrate
and optimize the majority of its top life sciences applications on IBM
"We recognize that innovation and efficiency are critical to drug
discovery and development and are very pleased to offer an expanded group of
Accelrys products on the IBM eServer pSeries ahead of schedule," said Dr.
Scott Kahn, general manager and senior vice president of Life Science for
Accelrys. "Our successful alliance with IBM and our aggressive timetable
enable us to stay a step ahead of our customers' needs and expectations."
Products ported to the IBM platform will initially operate on AIX servers
and will be designed to seamlessly integrate into the upcoming Discovery
Studio(TM) enterprise client-server environment. In addition, Accelrys
products that are Discovery Studio enabled will be available on a range of
server environments, including AIX and other proprietary versions of UNIX(TM)
as well as Windows NT and Linux. The product roadmaps have been specifically
designed and licensed to facilitate the transition from an isolated
workstation environment to a collaborative enterprise computing model,
recognizing the need to maintain data integrity, full application access and
the ability to scale and deploy high-performance compute resources
About Accelrys Inc.
Accelrys is a leading provider of software for computation, simulation,
and the management and mining of scientific data used by biologists, chemists,
and materials scientists for product design, drug discovery, and development.
Accelrys' platform technology and consulting services enable enterprise-wide
solutions tailored to today's leading research organizations. The company's
three main centers of excellence are in San Diego, CA, Princeton, NJ, and
Cambridge, UK. These centers combine research and product development with
facilities to support significant collaborative projects. Accelrys is a
subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP) and was launched in June 2001,
combining leading software companies Molecular Simulations Inc., Synopsys
Scientific Systems, Oxford Molecular, GCG, and Synomics Ltd.
More information on Accelrys can be found at http://www.accelrys.com.
Catalyst is a registered trademark of Accelrys Inc. within the United
States and/or various other countries. Discovery Studio is a trademark of
Accelrys Inc. within the United States and/or various other countries.
* Indicates trademark or registered trademark of IBM Corporation.
eServer, pSeries and AIX are registered trademarks of IBM Corporation.
UNIX is a registered trademark in the United States and other countries
licensed exclusively through The Open Group.
CONTACT: Jim Rivas of Accelrys, +1-858-799-5393, or firstname.lastname@example.org
MAKE YOUR OPINION COUNT - Click Here
SOURCE Accelrys, Inc.